A Randomised, Double-blind, Single-centre, Controlled Trial of Low Dose Intradermal Allergen Immunotherapy in Adults with Seasonal Allergic Rhinitis

Trial Profile

A Randomised, Double-blind, Single-centre, Controlled Trial of Low Dose Intradermal Allergen Immunotherapy in Adults with Seasonal Allergic Rhinitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jul 2015

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary) ; Histamine dihydrochloride
  • Indications Allergic rhinoconjunctivitis
  • Focus Therapeutic Use
  • Acronyms PollenLITE
  • Most Recent Events

    • 21 Mar 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 14 Mar 2013 Accrual to date is 103% according to United Kingdom Clinical Research Network.
    • 03 Dec 2012 Integrated new source: ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top